AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Aug 07 2020
Fact Check
Does Anthony Fauci Own ‘Half the Patent’ for Moderna’s COVID Vaccine?
In a recent debate with Alan Dershowitz, Robert Kennedy Jr. claimed that Dr. Anthony Fauci holds a patent for one of the drugs in vaccine trials for coronavirus. “The problem is Anthony Fauci put $500 million of our dollars into that vaccine [being produced by Moderna]. He owns half the patent,” said Kennedy. “He and these five guys who are working for him were entitled to collect royalties
The Dispatch
Oct 14 2021
News
FDA advisory panel unanimously endorses Moderna’s Covid vaccine booster for some groups
AFood and Drug Administration advisory panel voted unanimously Thursday in favor of authorizing booster shots of the Moderna Covid-19 vaccine to people 65 and older, those 18 to 64 with risk factors for severe Covid-19, and those whose jobs put them at high risk of serious complications of Covid-19, such as health care workers.
After hours of deliberation, the Vaccines and Related
STAT
Apr 13 2021
News
Moderna Says Covid Shot Remains 90% Effective After Six Months
Moderna Inc.’s coronavirus vaccine remained more than 90% effective after six months, according to a new analysis of data from the company’s final-stage trial.
Beginning two weeks after the second dose, the shot was more than 90% effective overall, and more than 95% effective at preventing severe cases, according to a statement. The company didn’t release further details and said the
Bloomberg
May 18 2020
News
Moderna's COVID-19 Vaccine Shows Promise in Early-Stage Study
Moderna Inc. said on Monday its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients.
The news sent Moderna shares (MRNA) soaring 25%.
The company's vaccine is at the forefront of the efforts in developing a treatment for the fast-spreading virus and last
Newsmax (News)
May 18 2020
News
Moderna reports 'positive' results from early data on coronavirus vaccine
The biotech company Moderna on Monday reported “positive” data on its potential coronavirus vaccine from an early clinical trial, raising hopes about the effort.
The company said early data from a phase one clinical trial showed that people given the potential vaccine generated an immune response similar to that in people who had recovered from the disease.
The levels of
The Hill
Mar 29 2021
News
One dose of Pfizer, Moderna COVID vaccine is 80% effective: CDC study
Just a single dose of either the Pfizer or Moderna vaccine was shown to be 80 percent effective in preventing COVID-19 in a new CDC study.
The high level of protection occurs within the first two weeks after receiving part one of the two-dose regime, researchers said.
“These interim vaccine effectiveness findings for both Pfizer-BioNTech’s and Moderna’s mRNA vaccines in real-
New York Post (News)
Jan 26 2021
News
Moderna’s COVID-19 Vaccine Works Against the New Mutant Strains. Is That Enough?
First, the good news: in a study published Jan. 25 on a preprint server, Moderna says its COVID-19 vaccine continues to protect against two of the major mutant strains of SARS-CoV-2 circulating around the world: one that was first identified in the U.K. (called B.1.1.7) and one first seen in South Africa (B.1.351).
Now, the not-so-good news. Blood from people vaccinated with the company
Time Magazine
Dec 15 2020
News
FDA review clears path for second coronavirus vaccine, this one developed by Moderna
By the end of the week, the United States could have two coronavirus vaccines.
A vaccine candidate developed by biotechnology company Moderna appears poised for regulatory clearance after a detailed data review by Food and Drug Administration scientists confirmed the two-shot regimen was 94 percent effective in a clinical trial and carried no serious safety concerns.
The FDA is
Washington Post
Apr 19 2023
News
Many seniors now eligible to get another COVID booster, CDC says
Many seniors can now get another COVID-19 vaccine booster, after the Centers for Disease Control and Prevention greenlighted a broad swath of changes on Wednesday that were first authorized by the Food and Drug Administration the day before. The CDC's move clears the final hurdle for eligible Americans to be able to get another round of the booster shots that were rolled out last year from
CBS News (Online)
Nov 19 2021
News
CDC panel, FDA OKs Moderna, Pfizer COVID-19 boosters for all US adults
A Centers for Disease Control and Prevention panel on Friday unanimously approved recommending booster shots of the Pfizer-BioNTech and Moderna vaccines for all adults.
The CDC panel said anyone 18 or above can get a third shot, while recommending that Americans over the age of 50 should get one. A final decision by the agency is expected later Friday.
Earlier in the day, the
New York Post (News)